Jamieson Wellness Inc

Sound bite for Twitter is: Dividend Growth Consumer. Debt Ratios are fine. Results of stock price testing is that the stock price is probably relatively cheap. The Dividend Payout Ratios (DPR) are good. The current dividend yield is moderate with dividend growth good. See my spreadsheet on Jamieson Wellness Inc.

Is it a good company at a reasonable price? I noticed that Money Sense has this stock on its latest list with a grade of D. This stock has only been on the TSX for 8 years. It is relatively small. It does have a fair bit of debt. It is relatively cheap based on dividends and DPRs are good. Most of my testing is saying that the stock price is relatively cheap.

I do not own this stock of Jamieson Wellness Inc (TSX-JWEL, OTC-JWLLF). This stock was written up in November 26, 2020 by Kay Ng on Motley Fool. She looked at what Warren Buffet was buying and pick some similar stocks, including Jamieson from TSX.

When I was updating my spreadsheet, I noticed that this company has only been on the stock exchange a short time (8 years), but has done well for shareholders in terms of stock price rising and dividend growth.

If you had invested in this company in December 2016, for $1,003.45 you would have bought 58 shares at $17.30 per share. In December 2024, after 8 years you would have received $222.72 in dividends. The stock would be worth $2,129.18. Your total return would have been $2,351.90. This would be a total return of 11.67% per year with 9.86% from capital gain and 1.81% from dividends.

Cost	Tot. Cost	Shares	Years	Dividends	Stock Val	Tot Ret
$17.30	$1,003.45	58	8	$222.72	$2,129.18	$2,351.90

The current dividend yield is moderate with dividend growth good. The dividend yield is moderate (2% to 4% ranges) at 2.40%. The 5, 10 and historical dividend yields are low (below 2%) at 1.80%, 1.48% and 1.48%. The dividend growth is good (15% per year or higher) at 20.11% per year over the past 5 years. The last dividend increase was in 2025 and it was for 10.53%.

The Dividend Payout Ratios (DPR) are good. The DPR for 2024 for Earnings per Share (EPS) is high at 67% with 5 year coverage at 55%. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is good at 49.7% with 5 year coverage at 44%. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 36% with 5 year coverage at 36%. The DPR for 2024 for Free Cash Flow (FCF) is good at 41% with 5 year coverage at 44%. There is some agreement on what FCF is.

Item	Cur	5 Years
EPS	67.23%	55.02%
AEPS	49.69%	43.92%
CFPS	36.19%	35.70%
FCF	40.52%	44.00%

Debt Ratios are fine. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.25 and currently at 0.20. The Liquidity Ratio for 2024 is good at 2.70 and 2.53 currently. The Debt Ratio for 2024 is good at 1.73 and 1.83 currently. The Leverage and Debt/Equity Ratios for 2024 are fine at 2.61 and 1.51 and currently at 2.39 and 1.31.

Type	Year End	Ratio Curr
Lg Term R	0.25	0.20
Intang/GW	0.49	0.43
Liquidity	2.70	2.53
Liq. + CF	2.72	2.69
Debt Ratio	1.73	1.83
Leverage	2.61	2.39
D/E Ratio	1.51	1.31

The Total Return per year is shown below for years of 5 to 8 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From	Years	Div. Gth	Tot Ret	Cap Gain	Div.
2019	5	20.11%	9.46%	7.35%	2.11%
2016	8	15.33%	11.67%	9.86%	1.81%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 25.84, 29.11, 33.11. The corresponding 8 year ratios are 24.81, 28.81 and 33.03. The current P/E Ratio is 18.44 based on a stock price of $35.03 and EPS estimate for 2025 of $1.90. The current ratio is below the low ratio of the 8 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I also have Adjusted Earning per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 20.70, 22.99 and 25.15. The corresponding 8 year ratios are 20.77, 25.08 and 29.41. The current P/AEPS is 18.44 based on a stock price of $35.03 and AEPS estimate for 2025 of 1.90. The current ratio is below the low ratio for the 8 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I get a Graham Price of $22.24. The 8-year low, median, and high median Price/Graham Price Ratios are 1.70, 1.96 and 2.28. The current P/GP Ratio is 1.58 based on a stock price of $35.03. The current ratio is below the low ratio of the 8 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I get an 8-year median Price/Book Value per Share Ratio of 3.36. The current P/B Ratio is 3.03 based on a stock price of $35.03, Book Value $485.3M and Book Value per Share of $11.57. The current ratio is 10% below the 8 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have a Book Value per Share estimate for 2025 of $12.68. This estimate implies a ratio of 2.76 and a Book Value of $531.9M with a stock price of $35.03. The current ratio is 18% below the 8 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get an 8-year median Price/Cash Flow per Share Ratio of 33.16. The current P/CF Ratio is 20.49 based on a stock price of $35.03, Cash Flow per Share estimate for 2025 of $1.71 and a Cash Flow of $71.7M. The current ratio is 38% below the 8 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical and 8 year median dividend yield of 1.48. The current dividend yield is 2.40% based on dividends of $0.84 and a stock price of $35.03. The current dividend yield is 62% above the historical and 8 year median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

The 8-year median Price/Sales (Revenue) Ratio is 2.48. The current ratio is 2.48 based on Revenue estimate for 2025 of $822.3M, Revenue per Share of $19.60 and a stock price of $35.03. The current ratio is 31% below the 8 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

Results of stock price testing is that the stock price is probably relatively cheap. The dividend yield test says that and it is confirmed by the P/S Ratio test. Most of the rest of the testing says the same thing except for the P/AEPS and that says the stock price is reasonable and below the median.

When I look at analysts’ recommendations, I find Strong Buy (5), Buy (4), and Hold (1). The consensus is a Strong Buy. The 12 month stock price consensus is $41.79 and a high of $43.50 and a low of $40.00. The consensus stock price of $41.79 implies a total return of 21.70% with 19.30% from capital gains and 2.40% from dividends based on a current stock price of $35.03.

Analysts in 2025 on Stock Chase give this stock a Hold, Watch and Buy, with the Buy being the last entry. Daniel Da Costa on Motley Fool likes this stock for its growth potential. Amy Legate-Wolfe on Motley Foll thinks this stock is a top stock in the TSX. The company put out a Press Release about their fourth quarter of 2024. The company put out a Press Release about their first quarter of 2025.

Simply Wall Street via Yahoo Finance reviews this stock. They said that Institutions own almost 62% of this company. They have one warning of has a high level of debt.

Jamieson Wellness Inc is engaged in the manufacturing, development, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. Some of its brands are Jamieson, Youtheory, Progressive, Precision, Smart Solutions, and Iron Vegan. Geographically, the majority of its revenue is derived from the domestic market. Its web site is here Jamieson Wellness Inc.

The last stock I wrote about was about was Premium Brands Holdings Corp (TSX-PBH, OTC-PRBZF) ... learn more. The next stock I will write about will be Suncor Energy Inc (TSX-SU, NYSE-SU) ... learn more on Friday, July 11, 2025 around 5 pm. Tomorrow on my other blog I will write about Something to Buy July 2025.... .... learn more on Thursday, July 10, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.